GO:0061659 ubiquitin-like protein ligase activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0061659 ubiquitin-like protein ligase activity describes the catalytic transfer of a ubiquitin-like protein (ULP) to a substrate lysine via an isopeptide bond, using an E2 or E3 thioester intermediate.
• This activity is distinct from canonical ubiquitination and covers modifiers such as SUMO, NEDD8, ISG15, and FAT10, each with dedicated E1, E2, and E3 enzymes.
• ULP ligases regulate diverse processes including autophagy, inflammasome activation, STING signaling, and cullin-RING ligase assembly.
• Dysregulation of ULP ligation is linked to cancer, neurodegeneration, and inflammatory diseases, making these enzymes attractive drug targets.
• Key experimental approaches include knockout, point-mutation, knock-in, and overexpression models, combined with proteomics and ubiquitin-like modification-specific assays.
• EDITGENE provides CRISPR-based services to dissect ULP ligase function, from library screening to bioinformatics, enabling publication-ready mechanistic studies.
Description
Ubiquitin-like protein (ULP) ligase activity, classified under GO:0061659, is a molecular function that catalyzes the covalent attachment of a ULP to a substrate protein. This reaction proceeds through a thioester-linked intermediate between the ULP C-terminus and an E2 or E3 enzyme, followed by isopeptide bond formation with a lysine residue on the substrate. ULP ligases are essential for the conjugation of modifiers such as SUMO, NEDD8, ISG15, and FAT10, which regulate protein stability, localization, and interactions. Researchers study this activity to understand how cells control signaling networks, stress responses, and immune defense. The importance of ULP ligase activity extends to human health. For example, PINK1 phosphorylates ubiquitin to activate Parkin, a process critical for mitophagy and Parkinson's disease. Neddylation, mediated by ULP ligases, controls cullin-RING ligase activity and is implicated in cancer and developmental disorders. ISGylation by HERCs facilitates STING activation, linking ULP ligation to antiviral immunity. SUMOylation of NLRP3 by TRIM28 stabilizes the inflammasome, affecting inflammatory responses. These examples highlight the broad impact of ULP ligases on cellular physiology and disease. Given the complexity of ULP ligation, precise experimental models are needed to dissect gene function. CRISPR-based knockout, point-mutation, knock-in, and overexpression strategies allow researchers to interrogate the roles of specific ULP ligases and their substrates. This article provides a comprehensive overview of GO:0061659, covering its definition, mechanisms, key genes, disease relevance, and research methods, with a focus on how EDITGENE's services can accelerate discovery.
ubiquitin-like protein ligase activity At A Glance
| GO ID | GO:0061659 |
|---|---|
| GO term | ubiquitin-like protein ligase activity |
| Ontology | molecular_function |
| Synonym | E3, small conjugating protein ligase activity |
| Definition | Catalysis of the transfer of a ubiquitin-like protein (ULP) to a substrate protein via X-ULP + S = X + S-ULP, where X is E2 or E3, X-ULP is a thioester, and S-ULP is an isopeptide bond between the C-terminal glycine of ULP and the epsilon-amino group of lysine residues in the substrate. |
| Major function | Conjugation of ubiquitin-like proteins (e.g., SUMO, NEDD8, ISG15) to target proteins, regulating their activity, localization, or stability. |
| Related activities | Ubiquitin-protein ligase activity (GO:0004842), SUMO ligase activity, NEDD8 ligase activity, ISG15 ligase activity. |
| Cellular context | Occurs in the cytoplasm and nucleus, often associated with E1, E2, and E3 enzyme cascades. |
| Pathological relevance | Dysregulation linked to cancer, neurodegeneration, and inflammatory diseases. |
What Is GO:0061659?
GO:0061659 ubiquitin-like protein ligase activity is defined as the catalysis of the transfer of a ubiquitin-like protein (ULP) to a substrate protein via the reaction X-ULP + S = X + S-ULP, where X is either an E2 or E3 enzyme, the X-ULP linkage is a thioester bond, and the S-ULP linkage is an isopeptide bond between the C-terminal glycine of ULP and the epsilon-amino group of lysine residues in the substrate. In simpler terms, it is the enzymatic activity that attaches a ULP molecule to a target protein, using a thioester intermediate and forming a stable isopeptide bond.
Why Is ubiquitin-like protein ligase activity Important in Cell Biology?
Ubiquitin-like protein ligase activity is crucial for maintaining cellular homeostasis by controlling the covalent attachment of ULP modifiers to thousands of target proteins. This post-translational modification system regulates diverse processes such as DNA repair, cell cycle progression, immune signaling, and autophagy. Defects in ULP ligation contribute to diseases including cancer, Parkinson's disease, and autoinflammatory disorders. Understanding this activity at the molecular level is therefore essential for developing targeted therapies and for interpreting disease-associated mutations.
• Regulates protein stability and function through covalent modification with SUMO, NEDD8, ISG15, and other ULPs.
• Controls cullin-RING ligase assembly via neddylation, impacting cell cycle and cancer.
• Mediates mitophagy through PINK1/Parkin pathway, relevant to Parkinson's disease.
• Modulates innate immune signaling, including STING activation by ISGylation.
• Influences inflammasome activation via SUMOylation of NLRP3.
• Plays a role in autophagy regulation under oxidative stress.
• Provides potential targets for anticancer and anti-inflammatory drugs.
• Enables researchers to study gene function using CRISPR knockout, knock-in, and point-mutation models.
• Facilitates the development of bioinformatics tools to predict ULP ligase substrates.
• Offers opportunities for library screening to identify novel regulators of ULP conjugation.
What Happens During ubiquitin-like protein ligase activity?
Activation of the Ubiquitin-like Protein by E1
In simple terms: First, the ULP is activated by an E1 enzyme using ATP.
The conjugation cascade begins with the ATP-dependent activation of the ULP by an E1 activating enzyme. This step involves adenylation of the ULP C-terminus and formation of a thioester bond between the ULP and the E1 catalytic cysteine. This activation is shared across ubiquitin and ULP pathways and is essential for subsequent transfer steps.
Transfer to E2 Conjugating Enzyme
In simple terms: The activated ULP is then passed to an E2 enzyme.
The E1 enzyme transfers the ULP to an E2 conjugating enzyme through a trans-thioesterification reaction, forming a new thioester bond between the ULP and the E2 catalytic cysteine. This E2-ULP intermediate is the central hub for substrate modification, and different E2 enzymes confer specificity for distinct ULPs and substrates.
Ligation to Substrate via E3 Enzyme
In simple terms: Finally, an E3 ligase helps attach the ULP to the target protein.
The E3 enzyme facilitates the transfer of the ULP from the E2 to a lysine residue on the substrate, forming an isopeptide bond. The reaction can proceed via a direct transfer from E2 to substrate or through an E3-ULP thioester intermediate, depending on the E3 family. This step determines substrate specificity and is tightly regulated.
Substrate Recognition and Specificity
In simple terms: E3 ligases recognize specific target proteins to ensure precise modification.
E3 ligases contain domains that bind specific substrates, often through post-translational modifications or interaction motifs. For example, TRIM28 SUMOylates NLRP3 to stabilize it, demonstrating how E3s select substrates. Similarly, Parkin is activated by PINK1-mediated phosphorylation of ubiquitin, illustrating a regulatory mechanism that enhances E3 activity.
Reversal and Regulation by Deconjugating Enzymes
In simple terms: The modification can be removed by enzymes called deubiquitinases or ULPs.
Deconjugating enzymes, such as deubiquitinases (DUBs) and ULP-specific proteases, cleave the isopeptide bond to remove the ULP from substrates. This reversibility is critical for dynamic regulation of ULP signaling. For instance, SENP proteases remove SUMO, while NEDP1 removes NEDD8, balancing ligase activity.
Key Genes Involved in GO:0061659 ubiquitin-like protein ligase activity
The following genes encode key enzymes and substrates involved in ubiquitin-like protein ligase activity, including E1, E2, E3 enzymes, and notable target proteins.
| Gene | Major Role | Research Relevance |
|---|---|---|
| UBA1 | E1 activating enzyme for ubiquitin | Essential for ubiquitin and ULP activation; mutations cause X-linked spinal muscular atrophy. |
| UBA2 | E1 activating enzyme for SUMO | Required for SUMOylation; knockout is embryonic lethal. |
| UBA3 | E1 activating enzyme for NEDD8 | Critical for neddylation; inhibition blocks cullin-RING ligase activity. |
| UBE2D1 | E2 conjugating enzyme | Mediates ubiquitin and ULP transfer; involved in DNA repair and signaling. |
| UBE2I (UBC9) | E2 conjugating enzyme for SUMO | Sole E2 for SUMOylation; essential for nuclear function. |
| UBE2M | E2 conjugating enzyme for NEDD8 | Works with RBX1/2 for cullin neddylation. |
| UBE2L6 | E2 conjugating enzyme for ISG15 | Facilitates ISGylation in antiviral immunity. |
| PARK2 (Parkin) | E3 ubiquitin ligase | Mutations cause Parkinson's disease; activated by PINK1. |
| PINK1 | Protein kinase | Phosphorylates ubiquitin to activate Parkin; mutations cause Parkinson's disease. |
| TRIM28 | E3 SUMO ligase | SUMOylates NLRP3 to promote inflammasome activation. |
| HERC5 | E3 ISG15 ligase | Mediates ISGylation of STING to enhance innate immunity. |
| RBX1 | RING-box protein | Component of cullin-RING ligases; neddylation substrate. |
| CUL1 | Cullin scaffold | Neddylated to activate SCF ligase; regulates cell cycle. |
| NLRP3 | Inflammasome sensor | SUMOylated by TRIM28; mutations linked to autoinflammatory diseases. |
| STING1 | Immune adaptor | ISGylated by HERC5; critical for antiviral response. |
| SENP1 | SUMO protease | Removes SUMO from substrates; regulates SUMOylation dynamics. |
| NEDP1 | NEDD8 protease | Deconjugates NEDD8; controls neddylation. |
| ATG7 | E1-like enzyme for ATG8/ULK | Involved in autophagy; ULP-like conjugation. |
How Is ubiquitin-like protein ligase activity Regulated?
Ubiquitin-like protein ligase activity is regulated at multiple levels. E3 ligases are often controlled by post-translational modifications; for example, PINK1 phosphorylates ubiquitin to activate Parkin. Neddylation is regulated by the availability of NEDD8 and the activity of deneddylases such as NEDP1. SUMOylation is dynamically balanced by SENP proteases. Additionally, oxidative stress can modulate autophagy through ULP-related pathways. These regulatory mechanisms ensure precise spatiotemporal control of ULP conjugation.
ubiquitin-like protein ligase activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| PINK1 | Parkinson's disease | Knockout or point-mutation knock-in in neuronal cells |
| PARK2 | Parkinson's disease | Knockout and overexpression in SH-SY5Y cells |
| NLRP3 | Autoinflammatory syndromes | Knock-in of SUMOylation site mutations in macrophages |
| STING1 | Antiviral immunity | Knockout and ISGylation-site mutants in fibroblasts |
| CUL1 | Cancer | Neddylation-deficient knock-in in cancer cell lines |
Cancer
Dysregulation of ULP ligases contributes to cancer through altered neddylation and SUMOylation. Overexpression of NEDD8 pathway components enhances cullin-RING ligase activity, promoting degradation of tumor suppressors. Targeting neddylation with inhibitors such as MLN4924 has shown anticancer efficacy in clinical trials. SUMOylation of oncoproteins and tumor suppressors also affects cancer progression, making ULP ligases attractive therapeutic targets.
Neurodegeneration
Mutations in PINK1 and Parkin, which mediate ubiquitin phosphorylation and ligation, cause early-onset Parkinson's disease. Impaired mitophagy due to defective ULP ligase activity leads to accumulation of damaged mitochondria and neuronal death. SUMOylation also regulates protein aggregation in neurodegenerative disorders, although direct links require further study.
Inflammatory and Immune Disorders
ULP ligases modulate innate immunity. ISGylation by HERC5 stabilizes STING and enhances antiviral responses. SUMOylation of NLRP3 by TRIM28 promotes inflammasome activation, and dysregulation is linked to autoinflammatory diseases. These findings highlight ULP ligases as potential targets for anti-inflammatory therapies.
From ubiquitin-like protein ligase activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does gene X encode a functional ULP ligase? | Knockout cell line followed by ULP conjugation assays |
| What is the role of a specific lysine in substrate modification? | Point-mutation knock-in of substrate lysine to arginine |
| How does a disease-associated mutation affect ligase activity? | Knock-in of patient mutation in isogenic cell lines |
| Where does the ligase localize in cells? | Tagged knock-in with fluorescent protein |
| Can overexpression drive ULP conjugation? | Overexpression of wild-type or mutant ligase |
| Which genes regulate ULP ligase activity? | CRISPR library screening with ULP-specific reporters |
How to Study the ubiquitin-like protein ligase activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Western blot with ULP-specific antibodies | Levels of conjugated vs. free ULP | Detecting global changes in ULPylation |
| Immunoprecipitation followed by mass spectrometry | Identity of ULP-modified proteins | Substrate discovery |
| In vitro ligation assay | Enzymatic activity of E1/E2/E3 | Mechanistic studies and inhibitor testing |
| CRISPR knockout screening | Genes required for ULP conjugation | Identifying novel regulators |
| Fluorescence microscopy | Subcellular localization of ULP ligases | Dynamic imaging |
| Proximity ligation assay | Interaction between E3 and substrate | Validating substrate specificity |
| Site-specific mutagenesis | Role of specific residues in ligation | Structure-function analysis |
| Bioinformatics pathway enrichment | Pathways enriched in ULP substrates | Data interpretation |
Proteomic Identification of ULP Substrates
Mass spectrometry-based proteomics can identify proteins modified by ULPs. Using tagged ULP or specific antibodies, researchers enrich modified peptides and map conjugation sites. This approach reveals substrate specificity and crosstalk between ULP pathways.
In Vitro Ligation Assays
Reconstituted systems with recombinant E1, E2, E3, and substrate are used to measure ULP ligase activity. These assays can test specific mutations and inhibitors, providing mechanistic insights.
CRISPR-Based Genetic Screens
Genome-wide CRISPR knockout or activation screens can identify genes that regulate ULP ligation. Reporters of ULP conjugation enable high-throughput screening for modifiers.
Imaging of ULP Dynamics
Fluorescently tagged ULPs or substrates allow live-cell imaging of conjugation and deconjugation. This method visualizes spatiotemporal dynamics of ULP ligase activity.
How CRISPR Can Be Used to Study GO:0061659 ubiquitin-like protein ligase activity
Knockout
CRISPR knockout of ULP ligase genes (e.g., PINK1, PARK2, TRIM28) eliminates protein function, allowing researchers to assess loss-of-function phenotypes such as impaired mitophagy or inflammasome activation. Knockout cell lines are essential for validating specific ligase-substrate relationships.
Point Mutation
Point mutations can be introduced to abrogate catalytic activity or disrupt substrate recognition. For example, mutating the catalytic cysteine of an E3 ligase or the acceptor lysine on a substrate can reveal its functional importance. These models are valuable for dissecting mechanism.
Knock-in
Knock-in of disease-associated mutations or tagged versions of ULP ligases enables study of mutant behavior in a physiological context. For instance, knock-in of Parkinson's disease-linked PINK1 mutations helps understand their impact on Parkin activation.
Overexpression
Overexpression of wild-type or mutant ULP ligases can amplify conjugation signals and facilitate detection of transient interactions. This approach is useful for identifying substrates and studying gain-of-function effects.
How EDITGENE Supports ubiquitin-like protein ligase activity Research
Researchers studying ubiquitin-like protein ligase activity-related genes often need to determine whether a candidate gene is causally involved in a specific biological process or disease. This requires precise genetic models that can knockout, mutate, or tag the gene of interest. EDITGENE provides a comprehensive suite of CRISPR services to accelerate such investigations, from initial screening to detailed mechanistic studies.
Contact EDITGENE today to design your custom CRISPR model for ubiquitin-like protein ligase activity research.
Frequently Asked Questions About ubiquitin-like protein ligase activity
What is ubiquitin-like protein ligase activity?
It is the enzymatic activity that attaches a ubiquitin-like protein (ULP) to a substrate protein via a thioester intermediate and an isopeptide bond, as defined by GO:0061659.
What genes are involved in ubiquitin-like protein ligase activity?
Key genes include E1 activating enzymes (UBA1, UBA2, UBA3), E2 conjugating enzymes (UBE2I, UBE2M, UBE2L6), and E3 ligases (PARK2, TRIM28, HERC5), among others.
How does ubiquitin-like protein ligase activity differ from ubiquitination?
It uses ubiquitin-like proteins such as SUMO, NEDD8, or ISG15 instead of ubiquitin, but the chemistry of thioester and isopeptide bond formation is similar.
What diseases are associated with defects in ubiquitin-like protein ligase activity?
Mutations in PINK1 and PARK2 cause Parkinson's disease; dysregulation of neddylation and SUMOylation is linked to cancer and inflammatory disorders.
How can I study ubiquitin-like protein ligase activity in the lab?
Common methods include knockout or knock-in cell models, in vitro ligation assays, proteomics, and CRISPR screens.
What is the role of neddylation in cancer?
Neddylation activates cullin-RING ligases, which degrade tumor suppressors; inhibitors like MLN4924 are in clinical trials.
Which E3 ligase is involved in Parkinson's disease?
Parkin (PARK2) is an E3 ubiquitin ligase activated by PINK1; mutations cause early-onset Parkinson's disease.
How is ISGylation linked to immunity?
ISGylation by HERC5 stabilizes STING and enhances antiviral signaling.
Can CRISPR be used to study ULP ligase function?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models are widely used to dissect ULP ligase roles.
What services does EDITGENE offer for ULP ligase research?
EDITGENE provides knockout, point mutation, knock-in, overexpression cell models, CRISPR library screening, and bioinformatics services.
Conclusion
GO:0061659 ubiquitin-like protein ligase activity is a fundamental molecular function that governs the covalent attachment of ULPs to target proteins, impacting nearly every cellular process. Its dysregulation is implicated in cancer, neurodegeneration, and immune disorders, making it a prime target for therapeutic intervention. By leveraging CRISPR-based models and advanced screening technologies, researchers can uncover the precise roles of individual ULP ligases and their substrates. EDITGENE stands ready to support these efforts with tailored services that accelerate discovery and translation.
References
- 1. Kane LA et al.. 2014. PINK1 phosphorylates ubiquitin to activate Parkin E3 ubiquitin ligase activity.. J Cell Biol 205(2):143-53 PMID: 24751536
- 2. Mevissen TET et al.. 2017. Mechanisms of Deubiquitinase Specificity and Regulation.. Annu Rev Biochem 86:159-192 PMID: 28498721
- 3. Huang DT et al.. 2004. Ubiquitin-like protein activation.. Oncogene 23(11):1958-71 PMID: 15021884
- 4. Enchev RI et al.. 2015. Protein neddylation: beyond cullin-RING ligases.. Nat Rev Mol Cell Biol 16(1):30-44 PMID: 25531226
- 5. Qin Y et al.. 2024. ISGylation by HERCs facilitates STING activation.. Cell Rep 43(5):114135 PMID: 38652662
- 6. Zhang S et al.. 2024. Protein neddylation and its role in health and diseases.. Signal Transduct Target Ther 9(1):85 PMID: 38575611
- 7. Zhou J et al.. 2022. Full-coverage regulations of autophagy by ROS: from induction to maturation.. Autophagy 18(6):1240-1255 PMID: 34662529
- 8. Qin Y et al.. 2021. TRIM28 SUMOylates and stabilizes NLRP3 to facilitate inflammasome activation.. Nat Commun 12(1):4794 PMID: 34373456
